Melanocyte-stimulating hormones (alpha- and gamma-MSH) regulate blood pressure through the sympathetic nervous system, and gamma-MSH deficiency causes salt-sensitive hypertension linked to insulin resistance.
Salt-sensitive hypertensionGamma-MSH deficiency in rodents causes severe salt-sensitive high blood pressure that can be corrected by delivering a small peptide dose directly to the brain
What the researchers found
Melanocyte-stimulating hormone peptides (melanocortins) play previously unrecognized roles in blood pressure regulation and sodium metabolism. Both alpha-MSH and gamma-MSH acutely raise blood pressure and heart rate by stimulating the sympathetic nervous system, but through different receptor mechanisms: alpha-MSH acts via the MC4R receptor, while gamma-MSH likely activates a central sodium channel rather than its MC3R receptor.
Paradoxically, gamma-MSH deficiency causes severe salt-sensitive hypertension — meaning too little of this peptide makes blood pressure dangerously responsive to salt intake. Delivering a small dose of gamma-MSH directly into the brain of deficient mice normalizes blood pressure. This salt-sensitive hypertension is also linked to the development of insulin resistance, though the connecting mechanism remains unknown and may involve sympathetic nervous system activation.
Why it matters
Salt-sensitive hypertension affects a large proportion of people with high blood pressure, and insulin resistance frequently accompanies it — but the link between the two has been poorly understood. This review reveals melanocortin peptides as a missing piece of the puzzle, connecting salt handling, blood pressure, sympathetic nervous activity, and metabolic dysfunction through a single peptide system. It also raises an important safety consideration for melanocortin drugs: their potential cardiovascular effects.
The numbers in context
Alpha-MSH acts via MC4R · Gamma-MSH acts via sodium channel (not MC3R) · Gamma-MSH deficiency → salt-sensitive hypertension · Cerebroventricular gamma-MSH restores normal BP in deficient mice · Salt-sensitive hypertension linked to insulin resistance
How the study worked
Narrative review published in Current Opinion in Nephrology and Hypertension, synthesizing recent findings on the cardiovascular and renal effects of melanocortin peptides from both animal models and mechanistic studies.
Who was studied
Not applicable (review of animal studies on melanocortin peptide cardiovascular effects)
What this study cannot tell us
Published in 2007, so more recent findings may have expanded on these observations. All cardiovascular and renal data discussed is from animal models — clinical translation to human hypertension has not been established. The mechanism linking salt-sensitive hypertension to insulin resistance via melanocortins was not yet determined at the time of publication.
How to read the evidence
Published in Current Opinion in Nephrology and Hypertension, a respected specialty journal. The review synthesizes well-conducted mechanistic animal studies, but all evidence is preclinical. The cardiovascular relevance of melanocortins in humans requires further investigation.
When this study was published
Published in 2007. The cardiovascular effects of melanocortins described here remain relevant, particularly as MC4R-targeting drugs have since entered clinical use. More recent studies have expanded on these findings.
The bigger picture
This review connects melanocortin biology to cardiovascular medicine in unexpected ways. MC4R agonists (like setmelanotide for genetic obesity) are now FDA-approved drugs, and understanding their cardiovascular effects is critical for patient safety. The finding that melanocortins link salt sensitivity to insulin resistance could explain why hypertension and metabolic syndrome so often co-occur — and why melanocortin-based drugs might affect blood pressure.
Questions still open
- Do MC4R agonist drugs like setmelanotide cause clinically significant blood pressure elevation in patients?
- Could gamma-MSH or its analogs be developed as treatments for salt-sensitive hypertension?
- What is the molecular mechanism linking melanocortin-mediated salt sensitivity to insulin resistance?
Common questions
Do melanocortin peptides affect blood pressure?
What is salt-sensitive hypertension and how do melanocortins relate to it?
Read the original research
Cardiovascular and renal actions of melanocyte-stimulating hormone peptides.
Current opinion in nephrology and hypertension, 16(1), 32-8
Citation
Humphreys, Michael H. (2007). Cardiovascular and renal actions of melanocyte-stimulating hormone peptides.. Current opinion in nephrology and hypertension, 16(1), 32-8.